Skip to main content
    P

    Perrigo Company PLC (PRGO)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $16.18
    -0.06 (-0.34%)

    Market Cap: $2.25B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Perrigo Company PLC (PRGO) Earnings: Report Dates and Results

    Updated Nov 4, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Sep 30, 2026, Perrigo Company reported EPS of $0.60, above the $0.56 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    65%(26/40)
    Avg Surprise
    +4.25%
    Streak
    3 Q

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus$0.77
    Range$0.73 - $0.81
    5 analysts
    Revenue Consensus
    $1.03B
    Range$953.54M - $1.10B
    5 analysts
    Report date not yet scheduledPeriod ending Mar 31, 2027
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A
    0 analysts

    Next Report

    PRGO's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    PRGO Earnings Call

    The latest PRGO earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, PRGO beat 26, missed 12 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $988.60M, down 4.9% from $1.04B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.60$0.56$0.50 - $0.58+7.14%Beat-25.0%30 up, 3 downNov 4, 2026$988.60M
    Jun 30, 2026$0.50$0.31N/A+61.29%Beat-12.3%40 up, 3 downAug 5, 2026$1.02B
    Mar 31, 2026$0.43$0.31$0.23 - $0.36+38.71%Beat-28.3%30 up, 1 downMay 6, 2026$969.20M
    Dec 31, 2025$0.77$0.80N/A-3.75%Miss+113.9%30 up, 1 downFeb 26, 2026$1.11B
    Sep 30, 2025$0.80$0.75$0.74 - $0.82+6.67%Beat-1.2%40 up, 1 downNov 5, 2025$1.04B
    Jun 30, 2025$0.57$0.59$0.55 - $0.62-3.39%Miss+7.5%30 up, 3 downAug 6, 2025$1.06B
    Mar 31, 2025$0.60$0.57$0.52 - $0.57+5.26%Beat+106.9%41 up, 0 downMay 7, 2025$1.04B
    Dec 31, 2024$0.36$0.95$0.87 - $0.95-62.11%Miss-58.1%40 up, 1 downFeb 27, 2025$1.14B
    Sep 30, 2024$0.81$0.81$0.80 - $0.830.00%In line+26.6%40 up, 1 downNov 6, 2024$1.09B
    Jun 30, 2024$0.53$0.46$0.40 - $0.49+15.22%Beat-15.9%30 up, 0 downAug 2, 2024$1.07B
    Mar 31, 2024$0.29$0.23$0.23 - $0.23+26.09%Beat-35.6%30 up, 0 downMay 7, 2024$1.08B
    Dec 31, 2023$0.86$0.83$0.78 - $0.87+3.61%Beat+14.7%30 up, 0 downFeb 27, 2024$1.16B
    Sep 30, 2023$0.64$0.63$0.59 - $0.64+1.59%Beat+14.3%20 up, 0 downNov 7, 2023$1.12B
    Jun 30, 2023$0.63$0.51$0.50 - $0.51+23.53%Beat+46.5%20 up, 0 downAug 8, 2023$1.19B
    Mar 31, 2023$0.45$0.43$0.39 - $0.44+4.65%Beat+36.4%30 up, 1 downMay 9, 2023$1.18B
    Dec 31, 2022$0.75$0.71N/A+5.63%Beat+25.0%20 up, 0 downFeb 27, 2023$1.16B
    Sep 30, 2022$0.56$0.67$0.62 - $0.74-16.42%Miss+24.4%40 up, 0 downNov 8, 2022$1.10B
    Jun 30, 2022$0.43$0.44$0.43 - $0.47-2.27%Miss-14.0%30 up, 1 downAug 9, 2022$1.12B
    Mar 31, 2022$0.33$0.42$0.41 - $0.43-21.43%Miss-34.0%30 up, 1 downMay 11, 2022$1.07B
    Dec 31, 2021$0.60$0.56N/A+7.14%Beat-35.5%N/A0 up, 0 downMar 1, 2022$1.10B
    Sep 30, 2021$0.45$0.65$0.63 - $0.67-30.77%Miss-51.6%3N/ANov 10, 2021$1.04B
    Jun 30, 2021$0.50$0.61$0.57 - $0.66-18.03%Miss-51.5%5N/AAug 11, 2021$981.10M
    Mar 31, 2021$0.50$0.57$0.52 - $0.62-12.28%Miss-56.1%7N/AMay 11, 2021$1.01B
    Dec 31, 2020$0.93$1.00$0.94 - $1.06-7.00%Miss-12.3%8N/AMar 1, 2021$1.29B
    Sep 30, 2020$0.93$0.86$0.78 - $0.89+8.14%Beat-10.6%8N/ANov 4, 2020$1.00B
    Jun 30, 2020$1.03$0.87$0.73 - $1.01+18.39%Beat+19.8%8N/AAug 5, 2020$948.80M
    Mar 31, 2020$1.14$1.04$0.73 - $1.13+9.62%Beat+6.5%9N/AApr 30, 2020$1.08B
    Dec 31, 2019$1.06$1.06$0.90 - $1.140.00%In line+9.3%10N/AFeb 27, 2020$1.32B
    Sep 30, 2019$1.04$0.94$0.81 - $0.99+10.64%Beat-4.6%11N/ANov 6, 2019$1.19B
    Jun 30, 2019$0.86$0.80$0.72 - $0.91+7.50%Beat-29.5%11N/AAug 8, 2019$1.15B
    Mar 31, 2019$1.07$0.93$0.60 - $1.17+15.05%Beat-15.1%10N/AMay 8, 2019$1.17B
    Dec 31, 2018$0.97$1.00$0.87 - $1.06-3.00%Miss-24.2%11N/AFeb 27, 2019$1.20B
    Sep 30, 2018$1.09$1.04$0.80 - $1.10+4.81%Beat-21.6%12N/ANov 8, 2018$1.13B
    Jun 30, 2018$1.22$1.20$1.12 - $1.30+1.67%Beat0.0%16N/AAug 9, 2018$1.19B
    Mar 31, 2018$1.26$1.14$1.01 - $1.22+10.53%Beat+20.0%17N/AMay 8, 2018$1.22B
    Dec 31, 2017$1.28$1.25$1.12 - $1.36+2.40%Beat-22.4%17N/AMar 1, 2018$1.28B
    Sep 30, 2017$1.39$1.11$0.94 - $1.18+25.23%Beat-15.8%16N/ANov 9, 2017$1.23B
    Jun 30, 2017$1.22$0.92$0.80 - $1.05+32.61%Beat-36.8%14N/AAug 10, 2017$1.24B
    Mar 31, 2017$1.05$0.99$0.93 - $1.04+6.06%Beat-40.0%14N/AMay 22, 2017$1.19B
    Dec 31, 2016$1.65$1.81$1.66 - $1.87-8.84%Miss-8.3%14N/AFeb 27, 2017$1.06B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $2.74, up 37.7% from the year before. It was $6.98 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$2.74+37.7%
    Dec 31, 2024$1.99-22.9%
    Dec 31, 2023$2.58+24.6%
    Dec 31, 2022$2.07N/A
    Dec 31, 2021$2.05-49.1%
    Dec 31, 2020$4.03N/A
    Dec 31, 2019$4.03-11.2%
    Dec 31, 2018$4.54-8.1%
    Dec 31, 2017$4.94-29.2%
    Dec 31, 2016$6.98N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,200 words across 7 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20265,2367
    2026Q2Jun 30, 20265,9817
    2026Q1Mar 31, 20265,2118
    2025Q4Dec 31, 20255,5228
    2025Q3Sep 30, 20255,1457
    2025Q2Jun 30, 20256,7087
    2025Q1Mar 31, 20256,2458
    2024Q4Dec 31, 202415,85014

    2026Q3 Earnings Call

    Opening remarks

    Eric Jacobson Vice President, Global Investor Relations Good morning and good afternoon, everyone. Welcome to Perrigo's third quarter 2026 earnings conference call. A copy of the release we issued today and the accompanying presentation are available within the Investors section of the perrigo.com website. Joining today's call are Perrigo's Interim President and CEO, Albert Manzone, and CFO, Eduardo Bezerra. As a reminder, we recently announced an agreement to divest our infant formula business. Beginning with the fourth quarter and full year 2026 reporting, the infant formula business will be reported as discontinued operations. Accordingly, the company's all-in outlook no longer includes infant formula. The company's core outlook continues to exclude infant formula and previously announced divestitures. During this presentation, participants will make certain forward-looking statements. Please refer to the slides for information regarding these statements, which are subject to important risks and uncertainties. We will reference adjusted financial measures that are non-GAAP in nature. See the appendix to the earnings presentation for additional details and reconciliations of all non-GAAP to GAAP financial measures presented. Moving to the agenda. Albert will begin with his perspective on Perrigo and the priorities he has identified. He will then discuss our third quarter performance, progress against the Three-S plan, and the commercial opportunities he sees to drive stronger, more consistent growth. Eduardo will then provide a financial review and discuss our 2026 outlook. With that, I'll turn it over to Albert.

    Albert Manzone Interim President and CEO Thanks, Eric. Good morning, good afternoon, and thank you for joining today's call. Over my first five months at Perrigo, I have spent a significant amount of time listening to our customers, our consumers, and our people, digging into the business and our capabilities, and developing a deeper understanding of what we do well and where we can be better. And I have been increasingly impressed. We have leading store brand products, strong brands, attractive positions across our categories, and a talented organization that knows the consumer self-care business exceptionally well. I want to thank our teams across Perrigo for their hard work, commitment, and the way they have welcomed me. At the same time, it has become clear why those strengths have not translated consistently into the results we should be delivering. Over time, Perrigo has become too complex. The business has not been integrated to the degree it needs to be, and that complexity has made it harder for our teams to execute with the necessary speed and focus. We are taking decisive action to simplify and strengthen Perrigo, and that process is a major focus for me. That means being extremely deliberate about where we invest, the businesses and geographies where we play, and how we organize ourselves.

    Frequently Asked Questions About PRGO

    Did PRGO beat earnings estimates last quarter?

    Yes. Perrigo Company reported EPS of $0.60 for the quarter ended Sep 30, 2026, above the $0.56 estimate, a 7.14% surprise.

    What EPS do analysts expect from PRGO next quarter?

    The consensus EPS estimate for Perrigo Company for the quarter ending Dec 31, 2026 is $0.77 from 5 analysts, with estimates from $0.73 to $0.81.

    How often does PRGO beat earnings estimates?

    Perrigo Company beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +6.23%.